Serotonin and the sleep/wake cycle: Special emphasis on microdialysis studies

Progress in Neurobiology

Volumn 60, Issue 1, 2000, Pages 13-35

  Portas, Chiara M ^a   Bjorvatn, Bjørn ^b   Ursin, Reidun ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; NORADRENALIN; SEROTONIN;

BRAIN REGION; BRAIN STEM; HUMAN; MICRODIALYSIS; NEUROTRANSMISSION; PRIORITY JOURNAL; REM SLEEP; REVIEW; SEROTONIN BRAIN LEVEL; SLEEP WAKING CYCLE;

ANIMALS; BRAIN; HUMANS; MICRODIALYSIS; SEROTONIN; SLEEP STAGES; WAKEFULNESS;

EID: 0033987287     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(98)00097-5     Document Type: Review

References (249)

1. Adell A., Artigas F. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. Naunyn-Schmiedeberg's Arch Pharmac. 343:1991;237.
2. Adell A., Carceller A., Artigas F. In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino) tetralin. J. Neurochem. 60:1993;1673.
3. 2 involved in the regulation of sleep and wakefulness? J. Sleep Res. 1:1992;176-177.
4. 1A receptors. Pharmac. Biochem. Behav. 57:1997;301-307.
5. Amin A.H., Crawford T.B.B., Gaddum J.H. The distribution of substance P and 5 hydroxytryptamine in the central nervous system of the dog. J. Physiol. 126:1954;596-618.
6. Auerbach S.B., Minzenberg M.J., Wilkinson L.O. Extracellular serotonin and 5-hydroxyindolacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release. Brain Res. 499:1989;281.
7. Baraban J.M., Aghajanian G.K. Noradrenergic innervation of serotonergic neurons in the dorsal raphe: demonstration by electron microscopic autoradiography. Brain Res. 204:1981;1.
8. Benveniste, H. and Hansen, A. J. (1991) Practical aspects of using microdialysis for determination of brain interstitial concentrations. In: Microdialysis in the Neurosciences, pp. 81-100. Eds. T. E. Robinson and J. B. Justice. Elsevier, Amsterdam.
9. 1A antagonist NAN-190. Brain Res. Bull. 39:1996;373-379.
10. 1A agonist 8-OH-DPAT and the NMDA antagonist AP-5 in rats. Brain Res. 692:1995;251-258.
11. Bjørkum A.A., Neckelmann D., Bjorvatn B., Ursin R. Lesion of descending serotonergic pathways increases zimeldine-induced waking in rats. Physiol. Behav. 57:1995;959-966.
12. Bjørkum A.A., Strecker R.E., Porkka-Heiskanen T., McCarley R.W. Perfusion of a 5-HT 1A antagonist in the dorsal raphe nucleus (DRN) increases serotonin (5-HT) and decreases REM sleep. Soc. Neurosci. Abstr. 22:1996;148.
13. Bjorvatn B., Ursin R. Effects of zimeldine, a selective 5-HT reuptake inhibitor, and ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats. Behav. Brain Res. 40:1990;239-246.
14. 1B agonist CGS 12066B, on sleep/waking stages and EEG power spectrum in rats. J. Sleep Res. 3:1994;97.
15. 1A antagonist (-)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in rats. Pharmac. Biochem. Behav. 42:1992;49-56.
16. Bjorvatn B., Bjørkum A.A., Neckelmann D., Ursin R. Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combination. Sleep. 18(6):1995;451-462.
17. 1B receptor activation. Behav. Pharmac. 7:1996;462-469.
18. 1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats. Brain Res. 770:1997;81-88.
19. 1A autoreceptors and increases serotonergic dorsal raphe unit activity in behaving cats. Eur. J. Pharmac. 356:1998;167-178.
20. Bland B.H. The physiology and the pharmacology of hippocampal formation theta rhythms. Prog. Neurobiol. 26:1986;1.
21. 1A receptors in the dorsal raphe and hippocampus: 1. Effect of spiperone. J. Pharmac. exp. Ther. 265:1993;7-15.
22. Blundell J.E. Is there a role for serotonin (5-hydroxytryptamine) in feeding? Int. J. Obesity. 1:1977;15.
23. Bonvento G., Scatton B., Claustre Y., Rouquier L. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neurosci. Lett. 137:1992;101.
24. Borbely A.A., Neuhaus H.U., Tobler I. Effect of p-chlorophenylalanine and tryptophan on sleep, EEG and motor activity in the rat. Behav. Brain Res. 2:1981;1.
25. Borbèly A.A., Trachsel L., Tobler I. Effect of ritanserin on sleep stages and sleep EEG in the rat. Eur. J. Pharmac. 156:1988;275-278.
26. Bouhuys A.L., van den Hoofdakker R.H. Effects of midbrain raphe destruction on sleep and locomotor activity in rats. Physiol. Behav. 19:1977;535-541.
27. 1B receptor. J. Sleep Res. 7(Suppl 2):1998;29.
28. Bradley, P. B. (1958) The effects of 5-hydroxytryptamine on the electrical activity of the brain and on behavior in the conscious cat. In: 5-Hydroxytryptamine, p. 214. Ed. G. P. Lewis. Pergamon Press, London.
29. Bradley P.B., Engel G., Feniuk W., Fozard J.R., Humphrey P.P.A., Middlemiss D.N., Mylecharane E.J., Richardson B.P., Saxena P.R. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology. 25:1986;563-576.
30. Brundege J.M., Dunwiddie T.V. Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv. Pharmac. 39:1997;351-391.
31. Cape E.G., Jones B.E. Differential modulation of high-frequency gamma-electroencephalogram activity and sleep-wake state by noradrenaline and serotonin microinjections into the region of cholinergic basalis neurons. J. Neurosci. 18:1998;2653-2666.
32. Carboni E., DiChiara G. Serotonin release estimated by transcorticaldialysis in freely moving rats. Neuroscience. 32:1989;637.
33. Cespuglio R., Faradji H., Gomez M.E., Jouvet M. Cooling of the raphe nucleus induces sleep in the cat. Neurosci. Lett. 3:1976;221-227.
34. Cespuglio R., Gomez M.E., Walker E., Jouvet M. Effect du refroidissement et de la stimulation des noyaux du systeme du raphe sur les etats de vigilance chez le chat. Electroenceph. clin. Neurophysiol. 47:1979;289.
35. Cespuglio R., Faradji H., Gomez M.E., Jouvet M. Single unit recording in the nuclei raphe dorsalis and magnus during the sleep-waking cycle of semi-chronic prepared cats. Neurosci. Lett. 24:1981;133-138.
36. Cespuglio R., Sarda N., Gharib A., Chastrette N., Houdouin F., Rampin C., Jouvet M. Voltammetric detection of the release of 5-hydroxyindole compounds throughout the sleep-waking cycle of the rat. Exp. Brain. Res. 80:1990;121.
37. Cespuglio R., Houdouin F., Oulerich M., El Mansari M., Jouvet M. Axonal and somato-dendritic modalities of serotonin release: their involvment in sleep preparation, triggering and manteinance. J. Sleep Res. 1:1992;150.
38. Chan-Palay, V. (1982) Serotonin neurons and their axons in the raphe dorsalis of rat and rhesus monkey: demonstration by high resolution autoradiography with 3H-serotonin. In: Cytochemical Methods in Neuroanatomy, pp. 357-386. Eds. V. Chan-Palay and S. L. Palay. Alan Liss, New York.
39. Chazal G., Ralston H.J. Serotonin-containing structures in the nucleus raphe dorsalis of the cat: an ultrastructural analysis of dendrites, presynaptic dendrites, and axonal terminals. J. comp. Neurol. 259:1987;317.
40. 1B/D receptor ligands. Pharmac. Ther. 62:1994;385-405.
41. Coccaro E.F. Impulsive aggression and central serotoninergic system function in humans; an example of a dimensional brain-behavior relationship. Int. Clin. Psychopharmac. 7:1992;3.
42. 1b receptors. J. Pharmac. exp. Ther. 277(2):1996;823.
43. Crespi F., Garratt J.C., Sleight A.J., Marsden C.A. In vivo evidence that 5-hydroxytryptamine (5-HT) neuronal firing and release are not necessarily correlated with 5-HT metabolism. Neuroscience. 35:1990;139.
44. Cropper E.C., Eisenman J.S., Azmitia E.C. An immunocytochemical study of the serotonergic innervation of the thalamus of the rat. J. comp. Neurol. 224:1984;38.
45. Dahlstrøm A., Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 62(Suppl.):1964;232.
46. Delorme F., Froment J.L., Jouvet M. Suppression du sommeil par la p-chlorometamphetamine et p-chlorophenylalanine. C.R. Soc. Biol. (Paris). 160:1966;2347-2351.
47. Dement W.C., Mitler M.M., Henriksen S.J. Sleep changes during chronic administration of parachlorophenylalanine. Rev. Can. Biol. 31(Suppl.):1972;239-246.
48. 1A agonist, on sleep patterns of healthy subjects. Psychopharmacology. 117:1995;186-192.
49. 2 receptors in the modulation of the sleep/wakefulness states. J. Sleep Res. 1:1992;163-168.
50. Dugovic C., Wauquier A. 5-HT2 receptors could be primarily involved in the regulation of slow wave sleep in the rat. Eur. J. Pharmac. 137:1987;145-146.
51. 2 receptors in the regulation of sleep and wakefulness in the rat. Psychopharmacology. 97:1989;436-442.
52. 1-like receptor agonists enhance wakefulness. Neuropharmacology. 31:1992;623-633.
53. 1B binding sites. Naunyn-Schmiedeberg's Arch. Pharmac. 332:1986;1-7.
54. Fallon, J. H. and Ciofi, P. (1992) Distribution of monoamines within the amygdala. In: The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction, pp. 97-114. Ed. J. P. Aggleton. Wiley-Liss, New York.
55. Fibiger H.C., Miller J.J. An anatomical and electrophysiological investigation of the serotonergic projection from the dorsal raphe nucleus to the substantia nigra in the rat. Neuroscience. 2:1977;975.
56. 1A agonist and antagonist drug administration in behaving cats. J. Pharmac. exp. Ther. 270:1994;1345-1358.
57. 1A antagonists BMY 7378, NAN 190 and (-)-propranolol on serotonergic dorsal raphe unit activity in behaving cats. J. Pharmac. exp. Ther. 270:1994;1359-1366.
58. 1A antagonist, increases serotonergic neuronal activity in behaving cats: Comparison with (S)-WAY-100135. J. Pharmac. exp. Ther. 278:1996;752-762.
59. Fornal C.A., Metzler C.W., Marrosu F., Ribiero-doValle L.E., Jacobs B.L. A subgroup of dorsal raphe serotonergic neurons in the cat is strongly activated during oral-buccal movements. Brain Res. 716:1996;123.
60. Fornal C.A., Martín F.J., Metzler C.W., Jacobs B.L. Pindolol suppresses serotonergic neuronal activity (by a WAY100635-sensitive mechanism) and does not block the neuronal inhibition produced by 8-OH-DPAT in awake cats. Soc. Neurosci. Abstr. 23:1997;973.
61. 1A receptor antagonist, WAY-100635. Eur. J. Pharmac. 281:1995;81-88.
62. Gallager D.W., Aghajanian G.K. Effect of antipsychotic drugs on the firing of dorsal raphe cells. I. Role of adrenergic system. Eur. J. Pharmac. 39:1976;341-355.
63. Gao B., Duncan W.C., Wehr T.A. Fluoxetine decreases brain temperature and REM sleep in Syrian hamsters. Psychopharmacology. 106:1992;321-329.
64. Gatzelu J.M., Buno W. Septo-hippocampal relationships during EEG theta rhythm. Electroencephalogr. Clin. Neurophysiol. 54:1982;532.
65. George R., Haslett W.L., Jenden D.J. A cholinergic mechanism in the brainstem reticular formation: induction of paradoxical sleep. Int. J. Pharmac. 3:1964;451-552.
66. 1A agonist, suppresses REM sleep equally in unmedicated depressed patients and normal controls. Neuropsychopharmacology. 15:1996;109-115.
67. Glass D.J., Hauser U.E., Randolph W.W. In vivo microdialysis of 5-hydroxyindolacetic acid and glutamic acid in the hamster suprachiasmatic nuclei. Am. Zool. 33:1993;212.
68. Grahame-Smith D.G. The biosynthesis of 5-hydroxytryptamine in the brain. Biochem. J. 105:1967;351-360.
69. 1 receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants. Neuropharmacology. 23:1984;655-661.
70. Green R.W., Gerber U., McCarley R.W. Cholinergic activation of medial pontine reticular formation neurons in vitro. Brain Res. 476:1989;154.
71. Hartmann E., Cravens J., List S. Hypnotic effects of L-tryptophan. Arch. Gen. Psychiat. 31:1974;394-397.
72. Hen R. Of mice and flies: commonalities among 5-HT receptors. Trends Pharmac. Sci. 13:1992;160-165.
73. Heym J., Trulson M.E., Jacobs B.L. Raphe unit activity in freely moving cats: effects of phasic auditory and visual stimuli. Brain Res. 232:1982;29.
74. Hilakivi I., Kovala T., Leppavuori A., Shvaloff A. Effects of serotonin and noradrenaline uptake blockers on wakefulness and sleep in cats. Pharmac. Toxic. 60:1987;161-166.
75. 1A agonist, 8-OH-DPAT, preferentially activates cell 5-HT autoreceptors in rat brain in vivo. Naunyn-Schmiedeberg's Arch Pharmac. 338:1988;463.
76. Hobson J.A., McCarley R.W., Wyzinski P.W. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science. 189:1975;55-58.
77. Honda T., Semba K. Serotonergic synaptic input to cholinergic neurons in the rat mesopontine tegmentum. Brain Res. 647:1994;299-306.
78. Houdouin F., Cespuglio R., Gharib A., Sarda N., Jouvet M. Detection of the release of 5-hydroxyndole compounds in the hypothalamus and the n. Raphe dorsalis throughout the sleep-waking cycle and during stressful situations in the rat: a polygraphic and voltammetric approach. Brain Res. 85:1991;153.
79. 1 recognition sites. J. Recept. Res. 8:1988;59-81.
80. Hoyer D., Martin G. 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology. 36:1997;419-428.
81. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmac. Rev. 46:1994;157-203.
82. Idzikowski C., Mills F.J., Glennard R. 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep. Brain Res. 378:1986;164-168.
83. Imeri L., De Simoni M.G., Giglio R., Clavenna A., Mancia M. Changes in the serotonergic system during the sleep-wake cycle: simultaneous polygraphic and voltammetric recordings in hypothalamus using a telemetry system. Neuroscience. 58(2):1994;353.
84. 1A receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex. Pharmac. Biochem. Behav. 54:1996;143-147.
85. Iwakiri H., Matsuyama K., Mori S. Extracellular levels of serotonin in the medial pontine reticular formation in relation to sleep-wake cycle in cats: a microdialysis study. Neurosci. Res. 18:1993;157.
86. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 72:1992;65.
87. Jacobs B.L., Fornal C.A. 5-HT and motor control: a hypothesis. Trends Neurosci. 16:1993;346.
88. Jones R.S.G. Responses of cortical neurons to stimulation of nucleus raphe medianus: a pharmacological analysis of the role of indolamines. Neuropharmacology. 21:1982;511.
89. Jouvet M. The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle. Ergebn. Physiol. 64:1972;166-307.
90. Jouvet M., Bobillier P., Pujol J.F., Renault J. Effects des lesions du system du raphe sur le sommeil et la serotonine cerebrale. C.R. Soc. Biol. Paris. 160:1967;2343.
91. Kemp I.R., Kaada B.R. The relation of hippocampal theta activity to arousal, attentive behaviour and somato-motor movements in unrestrained cats. Brain Res. 95:1975;342.
92. Kerkhofs M., Rielaert C., De Maertelaer V., Linkowski P., Czarka M., Mendlewicz J. Fluoxetine in major depression: efficacy, safety and effects sleep polygraph variables. Int. Clin. Psychopharmac. 5:1990;253-260.
93. Khateb A., Mühlethaler M., Alonso A., Serafin M., Mainville L., Jones B.E. Cholinergic nucleus basalis neurons display the capacity for rhythmic bursting activity mediated by low-threshold calcium spikes. Neuroscience. 51:1992;489-494.
94. Khateb A., Fort P., Alonso A., Jones B.E., Mühlethaler M. Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basalis neurons. Eur. J. Neurosci. 5:1993;541-547.
95. 1a receptors in the rat central nervous system. J. comp. Neurol. 365:1996;305.
96. Kiianmaa K., Fuxe K. The effects of 5,7-dihydroxytryptamine-induced lesions of the ascending 5-hydroxytryptamine pathways on the sleep-wakefulness cycle. Brain Res. 131:1977;287-301.
97. Kissinger, P. T. (1991) Microdialysis and liquid chromatography. In: Microdialysis in the Neurosciences, pp. 103-116. Eds. T. E. Robinson and J. B. Justice. Elsevier, Amsterdam.
98. 1B receptor agonist, CP-94,253. Drug Dev. Res. 26:1992;241-250.
99. Koella W. Neurohumoral aspects of sleep control. Biol. Psychiat. 1:1969;161-177.
100. Koella W.P., Czicman J.S. Mechanism of the EEG-synchronizing action of serotonin. Am. J. Physiol. 211:1966;926-934.
101. Koella W.P., Feldstein A., Czicman J.S. The effect of para-chlorophenylalanine on the sleep of cats. Electroenceph. Clin. Neurophysiol. 25:1968;481-490.
102. Koyama Y., Hayaishi O. Firing of neurons in the preoptic/anterior hypothalamic area in rat: its possible involvement in slow wave sleep and paradoxical sleep. Neurosci. Res. 19:1994;31.
103. Krettek J.E., Price J.L. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. J. comp. Neurol. 178:1978;225.
104. Krnjevic K., Pumain R., Renaud L. The mechanism of exitation by acetylcholine in the cerebral cortex. J. Physiol. London. 215:1971;447.
105. Kupfer D.J., Shipley J.A., Perel J.M., Pollock B., Coble P.A., Spiker D.G. Antidepressants and EEG sleep: search for specificity. Psychopharmac. Ser. 3:1987;167-173.
106. 1A receptor ligands (+)-WAY 100 135 and SDZ 216-525. Eur. J. Pharmac. 249:1993;25-35.
107. Lavoie B., Parent A. Serotonergic innervation of the thalamus in primate: an immunohistochemical study. J. comp. Neurol. 312(1):1991;1.
108. Le Bars, D. (1994) Serotonin and pain. In: Neuronal Serotonin, pp. 171-229. Eds. N. N Osborne and M. Hamon. Wiley, New York.
109. Lee K.H., McCormick D.A. Abolition of spindle oscillations by serotonin and norepinephrine in the ferret lateral geniculate and periogeniculate nuclei in vitro. Neuron. 17:1996;309-321.
110. Lelkes Z., Obal F., Alfódi P., Erdos A., Rubicsek G., Benedek G. Effects of acute and chronic treatment with trazodone, an antidepressant, on the sleep-wake activity in the rat. Pharmac. Res. 30:1994;105-115.
111. Leonard C.S., Llinas R. Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep: an in vitro electrophysiological study. Neuroscience. 59:1994;309.
112. Levine E.S., Jacobs B.L. Neurochemical afferents controlling the activity of serotonergic neurons in the dorsal raphe nucleus: microintophoretic studies in the awake cat. J. Neurosci. 12:1992;4037-4044.
113. Lin J.S., Sakai K., Vanni-Mercier G., Jouvet M. A critical role of the posterior hypothalamus in the mechanisms os wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res. 479:1989;225.
114. Lin J.S., Luppi P.H., Salvert D., Sakai K., Jouvet M. Neurones immunoreactifs a l'histamine dans l'hypothalamus chez le chat. C.R. Acad. Sc. Paris. 303(serie III, 9):1993;371.
115. Lucas E.A., Sterman M.B. Effects of a forebrain lesion on the polycyclic sleep-wake cycle and sleep-wake patterns in the cat. Exp. Neurol. 46:1975;368.
116. 1 receptors and behavior. Neurosci. Biobehav. Rev. 16:1992;83-93.
117. Luebke J.I., Greene R.W., Semba K., Kamondi A., McCarley R.W., Reiner P.B. Serotonin hyperpolarizes cholinergic low threshold burst neurons in the rat laterodorsal tegmental nuclei in vitro. Proc. natl Acad. Sci. U.S.A. 89:1992;743.
118. Luppi P.H., Gervasoni D., Peyron C., Rampon C., Barbagli B., Boissard R., Fort P. GABAergic and glycinergic afferents to the dorsal raphe and locus coeruleus nuclei. J. Sleep Res. 7(Suppl. 2):1998;165.
119. Lydic R., McCarley R.W., Hobson J.A. Serotonin neurons and sleep II Time course of dorsal raphe discharge, PGO waves and behavioral states. Arch. Ital. Biol. 126:1987;1.
120. Maes, M. and Meltzer, H. Y. (1995) The serotonin hypothesis of major depression, In: Psycopharmacology: the Fourth Generation of Progress, pp. 933-944. Eds. F. E. Bloom and D. J. Kupfer. Raven Press, New York.
121. Maudhuit C., Jolas T., Lainey E., Hamon M., Adrien J. Effects of acute an chronic treatment with amoxapine and cericlamine on the sleep-wakefulness cycle in the rat. Neuropharmacology. 33:1994;1017-1025.
122. Mantz J., Godbout R., Tassin J.P., Glowinski J., Thierry A.M. Inhibition of spontaneous and evoked unit activity in the rat medial prefrontal cortex by mesencephalic raphe nuclei. Brain Res. 524:1990;22.
123. Marinesco S., Gonzalez-Mora J.L., Jouvet M., Cespuglio R. Electrochemical detection of serotonin in vivo with nafion coated microelectrodes. J. Sleep Res. 5(Suppl. 1):1996;133.
124. 1A receptors. Brain Res. 739:1996;192.
125. Marsden C.A., Sleight A.J., Fone K.C.F., Jonson J.V., Crespi F., Martin K.F., Garrett J.C., Bennett G.W. Functional identification of 5HT receptor subtypes. Comp. Biochem. Physiol. 93A:1989;107-114.
126. Maru E., Takahashi L.K., Iwahara S. Effects of median raphe nucleus lesions on hippocampal EEG in the freely moving rat. Brain Res. 163:1979;223.
127. Matsumura H., Nakajima T., Osaka T., Satoh S., Kawase K., Kubo E., Kantha S.S., Kasahara K., Hayaishi O. Prostaglandin D2-sensitive, sleep-promoting zone defined in the ventral surface of the rostral basal forebrain. Proc. natl Acad. Sci. U.S.A. 91:1994;11998.
128. McCarley R.W., Ito K. Intracellular evidence linking medial pontine reticular formation neurons to PGO wave generation. Brain Res. 280:1983;58.
129. McCarley R.W., Hobson J.A. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. Science. 189:1975;58.
130. McCarley R.W., Greene R.W., Rainnie D.G., Portas C.M. Brainstem neuromodulation and REM sleep. Semin. Neurosci. 8:1995;341.
131. McCormick D.A. Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog. Neurobiol. 39:1992;337.
132. McCormick D.A., Wang Z. Serotonin and noradrenaline excite GABAergic neurones of the guinea pig and cat thalamic reticular nucleus. J. Physiol. London. 442:1991;235.
133. McEntee W.J., Crook T.H. Serotonin, memory and the aging brain. Psychopharmacology. 103:1991;143.
134. McGinty D., Harper R.M. Dorsal raphe neurons: depression of firing during sleep in cats. Brain Res. 101:1976;569.
135. McGinty D.J., Sterman M.B. Sleep suppression after basal forebrain lesions in the cat. Science. 160(833):1968;1253.
136. McQuade R., Sharp T. Release of cerebral 5-hydroxytryptamine evoked by electrical stimulation of the dorsal and median raphe nuclei: effect of a neurotoxic amphetamine. Neuroscience. 68(4):1995;1079.
137. Mendelson W.B., Martin J.V., Perlis M., Wagner R. Enhancement of sleep by microinjection of triazolam into the medial preoptic area. Neuropsychopharmacology. 2:1989;61.
138. Mendlin A., Martin F.J., Rueter L.E., Jacobs B.L. Neuronal release of serotonin in the cerebellum of behaving rats: an in vivo microdialysis study. J Neurochem. 67:1996;617-622.
139. Mercier G., Sakai K., Jouvet M. Neurones specifiques del'eveil dans l'hypothalamus posterieur du chat. C.R. Acad. Sci. Paris. 298(serie III, 7):1984;195.
140. Meston C.M., Gorzalka B.B. Psychoactive drugs and human sexual behavior: the role of serotonergic activity. J. Psychoactive Drugs. 24:1992;1.
141. 1B receptors. Ann. N.Y. Acad. Sci. 600:1990;132-148.
142. Middlemiss D.N., Tricklebank M.D. Centrally active 5-HT receptor agonists and antagonists. Neurosci. Biobehav. Rev. 16:1992;75-82.
143. 1A antagonists. J. Pharmac. exp. Ther. 268:1994;337-352.
144. Mitani A., Ito K., Hallanger A.E., Wainer B.H., Kataoka K., McCarley R.W. Cholinergic projections from the laterodorsal and peduncolopontine tegmental nuclei to the pontine gigantocellular tegmental field in the cat. Brain Res. 451:1988;397.
145. Moir A.T.B., Eccleston D. The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles. J. Neurochem. 19:1968;1093-1108.
146. Montagne, M. and Calas, A. (1988) Serotonin and endocrinology: the pituitary. In: Neuronal Serotonin, pp. 271-303. Eds. N. N. Osborne and M. Hamon. Wiley, New York.
147. 1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat. J. Sleep. Res. 1:1992;169-175.
148. Monti J.M., Jantos H. Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulness. Neuropharmacology. 33:1994;705-708.
149. Monti J.M., Pineyro G., Orellana C., Boussard M., Jantos H. 5-HT receptor agonists DOI and 8-OH-DPAT increase wakefulness in the rat. Biogenic Amines. 7:1990;145-151.
150. 1B receptor with CP-94,253 on sleep and wakefulness in the rat. Neuropharmacology. 34:1995;1647-1651.
151. Monti J.M., Jantos H., Silveira R., Reyesparada M., Scorza C. Sleep and waking in 5,7-DHT-lesioned or (-)-pindolol- pretreated rats after administration of buspirone, ipsapirone, or gepirone. Pharmac. Biochem. Behav. 52:1995;305-312.
152. Moret C., Briley M. The unique effect of methiothepin on the terminal serotonin autoreceptor in the rat hypothalamus could be an example of inverse agonism. J. Psychopharmac. 7:1993;331-337.
153. Morrison J.H., Foote S.L. Noradrenergic and serotonergic innervation of cortical, thalamic, and tectal visual structures in old and new world monkeys. J. comp. Neurol. 243:1986;117.
154. Mundal V., Bjorvatn B. Sleep and waking following microdialysis perfusion of a 5-HT antagonist into the dorsal raphe nucleus in rats. Soc. Neurosci. Abstr. 23:1997;978.
155. Mühlethaler M. Electrophysiological properties and neuromodulation of cholinergic and non-cholinergic basal forebrain neurones. J. Sleep Res. 3:1994;173.
156. Myers, R. D. (1980) Hypothalamic control of thermoregulation. In: Handbook of the Hypothalamus, Vol. 3 pp. 83-210. Eds. P. J. Morgane and J. Panksepp. Marcel Dekker, New York.
157. Nakahara D., Yukie M., Iwahara S. Effects of atropine sulphate upon hippocampal theta activity and eye movements during different behavioral states of cats. Jap. Psychol. Res. 19:1977;9.
158. Nauta W.J.H. Hypothalamic regulation of sleep in rats. An experimental study. J. Neurophysiol. 9:1946;285.
159. Neale R.F., Fallon S.L., Boyar W.C., Wasley J.W.F., Martin L.L. Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-1B agonist. Eur. J. Pharmac. 136:1987;1-9.
160. 1A antagonist NAN-190 alone and in combination with citalopram. Behav. Brain Res. 75:1996;159-168.
161. Nicholson A.N., Pascoe P.A. 5-Hydroxytryptamine and noradrenaline uptake inhibition: studies on sleep in man. Neuropharmacology. 25:1986;1079-1084.
162. Nicolaidis, S. (1986) Serotonergic System, Feeding and Body Weight Regulation. Academic Press, London.
163. Nitz D., Siegel J. GABA release in the dorsal raphe nucleus: role in the control of REM sleep. Am. J. Physiol. 273:1997;R451-R455.
164. Nitz D., Siegel J.M. GABA release in the mesopontine central grey as a function of sleep state. Am. J. Physiol. 271(6Pt 2):1996;1707.
165. Nuñez A. Unit activity of rat basal forebrain neurons: relationship to cortical activity. Neuroscience. 72:1996;757-766.
166. Ögren S.O., Holm A.C., Hall H., Lindberg U. Alaproclate, a new selective 5-HT uptake inhibitor with therapeutic potential in depression and senile dementia. J. Neural Transmission. 59:1984;265-288.
167. Okada M., Kawata Y., Kiryu K., Mizuno K., Wada K., Tasaki H., Kaneko S. Effects of adenosine receptor subtypes on hippocampal extracellular serotonin level and serotonin reuptake activity. J. Neurochem. 69:1997;2581-2588.
168. Olivier B., Mos J. Rodent models of aggressive behavior and serotonergic drugs. Prog. Neuropsychopharmac. Biol. Psychiat. 16:1992;847.
169. Olsen Ø.E., Neckelmann D., Ursin R. Diurnal differences in L-tryptophan sleep and temperature effects in the rat. Behav. Brain Res. 65:1994;195-203.
170. Orosco M., Rouch C., de Saint-Hilaire Z., Nicolaidis S. Dynamic changes in hypothalamic monoamines during sleep/wake cycles assessed by parallel EEG and microdialysis in the rat. J. Sleep Res. 4:1995;144.
171. Pastel R.H., Fernstrom J.D. Short-term effects of fluoxetine and trifluoromethylphenylpiperazine on electroencephalographic sleep in the rat. Brain Res. 436:1987;92-102.
172. 1A receptors on dorsal raphe neurones of the adult rat. J. Physiol. 469:1993;387.
173. Peroutka S.J. 5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization. TINS. 11:1988;496-500.
174. Petitjean F., Buda C., Janin M., Sakai K., Jouvet M. Patterns of sleep alterations following selective raphe nuclei lesions. Sleep Res. 7:1978;40.
175. Pivik R.T., McCarley R.W., Hobson J.A. Eye movement-associated discharge in brain stem neurons during desynchronized sleep. Brain Res. 121:1977;59.
176. 3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat. Eur. J. Pharmac. 249:1993;259-264.
177. Ponzoni A., Monti J.M., Jantos H., Altier H., Monti D. Increased waking after intra-accumbens injection of m-chlorophenylbiguanide: prevention with serotonin or dopamine receptor antagonists. Eur. J. Pharmac. 278:1995;111-115.
178. Portas C.M., McCarley R.W. Behavioral state-related changes of extracellular serotonin concentration in the dorsal raphe nucleus in the freely moving cat. Brain Res. 648:1994;306.
179. Portas C.M., Thakkar M., Rainnie D.G., McCarley R.W. Microdialysis
180. Portas C.M., Bjorvatn B., Fagerland S., Sorenson E., Mundal V., Ursin R. On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat. Neuroscience. 83(3):1998;807.
181. Puizillout J.J., Gaudin-Chazal G., Daszuta A., Seyfritz N., Ternaux J.P. Release of endogenous serotonin from "encéphale isolé" cats. 2. Correlation with raphe neuronal activity and sleep and wakefulness. J. Physiol. (Paris). 75:1979;531-537.
182. Pujol J.-F., Buguet A., Froment J.-L., Jones B., Jouvet M. The central metabolism of serotonin in the cat during insomnia. A neurophysiological and biochemical study after administration of p-chlorophenylalanine. Brain Res. 29:1971;195-212.
183. Radja F., Laporte A.M., Daval G., Verge D., Gozlan H., Hamon M. Autoradiography of serotonin receptor subtypes in the central nervous system. Neurochem. Int. 18:1991;1.
184. Rapport M.M., Green A.A., Page I.H. Purification of the substance which is responsible for the vasoconstrictor activity of serum. Federation Proc. 6:1947;184.
185. Riou R., Cespuglio R., Jouvet M. Endogenous peptides and sleep in the rat. III. The hypnogenic properties of vasoactive intestinal peptide. Neuropeptides. 2:1982;265.
186. Robinson T.E. Hippocampal rhythmic slow activity (RSA; theta): a critical analysis of selected studies and discussion of possible species-differences. Brain Res. Rev. 2:1980;69.
187. Rueter L.E., Jacobs B.L. A microdialysis examination of serotonin release in the rat forebrain induced by behavioral/environmental manipulations. Brain Res. 739:1996;57.
188. Sakai, K., Sarstre, J., Kanamori, N. and Jouvet, M. (1982) State specific neurons in the ponto-medullary reticular formation with special reference to the postural atonia during paradoxical sleep in the cat. In: Brain Mechanisms of Perceptual Awareness and Purposeful Behavior, Eds. C. Agmone-Marsan and O. Pompeiano. Raven Press, New York.
189. Sallanon M., Denoyer M., Kitahama K., Aubert C., Gay N., Jouvet M. Long-lasting insomnia induced by preoptic neuron lesions and its transient reversal by muscimol injection into the posterior hypothalamus in the cat. Neuroscience. 32:1989;669.
190. Sanford L.D., Ross R.J., Seggos A.E., Morrison A.R., Ball W.A., Mann G.L. Central administration of two 5-HT receptor agonists: effect on REM sleep initiation and PGO waves. Pharmac. Biochem. Behav. 49:1994;93-100.
191. Sanford L.D., Tejani-Butt S.M., Ross R.J., Morrison A.R. Amygdaloid control of alerting and behavioral arousal in rats: involvement of serotonergic mechanisms. Arch.-Ital.-Biol. 134(1):1995;81.
192. 1B serotonin receptor: cloning, functional expression, and localization in motor control centers. In: Serotonin, the Cerebellum, and Ataxia, pp 201-209. Eds. P. Trouillas and K. Fuxe. Raven Press, New York.
193. Scatton, B., Rouquier, L., Bonvento, G., Serrano, A. and Blier, P. (1992) Autoreceptor-mediated control of serotonin release in the rat brain in vivo. In: Advances in the Biosciences, Eds. S. L. Langer, A. M. Galzin and J. Costentin. Pergamon Press, Oxford.
194. 1B receptor ligands exist? Naunyn-Schmiedeberg's Arch. Pharmac. 339:1989;675-683.
195. Schram, S. B. (1981) The LDC basic book on liquid chromatography. Milton Roy Company, St. Petersburg, FL.
196. 1A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade. Neurosci. Lett. 209:1996;41-44.
197. 1A antagonist pindolol: possible disinhibition of raphe neuron activity. Brain Res. 759:1997;84-91.
198. Semba K., Fibiger H. Afferent connections of the laterodorsal tegmental nucleus: efferent and afferent connections. J. comp. Neurol. 253:1986;277.
199. 1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo. Br. J. Pharmac. 109:1993;699-702.
200. 2C receptors. Neuropharmacology. 33:1994;467-471.
201. Sharpley A.L., Williamson D.J., Attenburrow M.E.J., Pearson G., Sargent P., Cowen P.J. The effects of paroxetine and nefadozone on sleep: a placebo controlled trial. Psychopharmacology. 126:1996;50-54.
202. Sherin J.E., Shiromani P.J., McCarley R.W., Saper C.B. Activation of ventralpreoptic neurons during sleep. Science. 271:1996;216.
203. Shiromani P.J., Armstrong D.A., Berkowitz A., Jeste D.V., Gillin J.C. Distribution of choline acetyltransferase immunoreactive somata in the feline brainstem: implications for REM sleep generation. Sleep. 11:1988;1-16.
204. 2 antagonist ritanserin on sleep-waking cycle in the rat. Pharmac. Biochem. Behav. 41:1991;241-243.
205. Sommerfelt L., Ursin R. The effects of zimeldine and alaproclate combined with a small dose of 5-HTP on waking and sleep stages in cats. Behav. Brain Res. 24:1987;1-10.
206. Sommerfelt L., Ursin R. Behavioral, sleep-waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimeldine and alaproclate in cats. Behav. Brain Res. 45:1991;105-115.
207. Sommerfelt L., Ursin R. The 5-HT2 antagonist ritanserin decreases sleep in cats. Sleep. 16:1993;15-22.
208. Sommerfelt L., Hauge E.R., Ursin R. Similar effect on REM sleep but differential effect on slow wave sleep of the two 5-HT uptake inhibitors zimeldine and alaproclate in cats and rats. J. Neural Transm. 68:1987;127-144.
209. Sørensen, E., Bjorvatn, B. and Ursin, R. (1998a) A dose-response study of the selective 5-HT 1A antagonist p-MPPI on sleep-wake stages in the rat. J. Sleep Res. suppl 1, 257.
210. Sørensen, E., Bjorvatn, B. and Ursin, R. (1998b) p-MPPI antagonizes sleep as well as behavioral effects of 8-OH-DPAT in the freely moving rat. Soc. Neurosci. Abstr. 695.
211. Sotelo C., Cholley B., El Mestikawy S., Gozlan H., Hamon M. Direct immunoistochemical evidence of the existence of 5-HT1a autoreceptors on 5-HT neurons in the midbrain raphe nuclei. Eur. J. Neurosci. 2:1990;1144.
212. Soubrie, P. (1988) Serotonin and behavior, with special regard to animal models of anxiety, depression and waiting ability. In: Neuronal Serotonin, pp. 255-270. Eds. N. N Osborne and M. Hamon. Wiley, New York.
213. Spinweber L.C., Ursin R., Hilderbrand R.L. The effect of L-tryptophan effects on daytime sleep latency and the waking EEG. Electroenceph. Clin. Neurophysiol. 55:1983;652-661.
214. 1B agonists. Synapse. 1:1987;3.
215. Ståle, L. (1991) The use of microdialysis in pharmacokinetics and pharmacodynamics. In: Microdialysis in the Neurosciences, pp. 155-174. Eds. T. E. Robinson and J. B. Justice. Elsevier, Amsterdam.
216. Steriade M. Basic mechanisms of sleep generation. Neurology. 42:1992;9-17.
217. Steriade, M. and McCarley, R. W. (1990) Brainstem Control of Wakefulness and Sleep. Plenum Press, New York.
218. Steriade M., McCormick D.A., Sejnowski T.J. Thalamocortical oscillations in the sleeping and aroused brain. Science. 262:1993;679-685.
219. Strecker R.E., Porkka-Heiskanen T., Bjørkum A.A., McCarley R.W. Adenosine actions on the dorsal raphe nucleus: Altered sleep-waking pattern. Soc. Neurosci. 419.8:1997;1065.
220. Szymusiak R., McGinty D. Sleep suppression following kainic acid-induced lesions of the basal forebrain. Exp. Neurol. 94:1986;598.
221. 1A receptor activation in vivo. Life Sci. 56:1995;PL163-PL168.
222. Thielen R.J., Fangon N.B., Frazer A. 4-(2′-Methoxyphenyl)-1-[2′-[N-(2″-pyridinyl)-p-iodobenzamido] ethyl]piperazine and 4-(2′-methoxyphenyl)-1-[2′-[N-(2″-pyridinyl)-p- fluorobenzamido] ethyl]piperazine, two new antagonists at pre- and postsynaptic serotonin-1A receptors. J. Pharmac. exp. Ther. 277:1996;661-670.
223. 1A agonist, on sleep/wakefulness cycles: probable post-synaptic action. J. Sleep Res. 2:1993;103-109.
224. Tobler I., Borbely A.A. The effect of 3-h and 6-h sleep deprivation on sleep and EEG spectra of the rat. Behav. Brain Res. 36:1990;73-78.
225. Trent F., Tepper J.M. Dorsal raphe stimulations modifies striatal evoked antidromic invasion of nigral dopamine neurons in vivo. Exp. Brain Res. 84:1991;620.
226. 1 receptor agonist, RU 24969, in the rat. Neuropharmacology. 25:1986;877-886.
227. Trulson M.E., Jacobs B.L. Raphe unit activity in freely moving cats: correlation with level of behavioural arousal. Brain Res. 163:1979;135.
228. Ungerstedt, U. (1991) Introduction to intracerebral microdialysis. In: Microdialysis in the Neurosciences, pp. 3-22. Eds. T. E. Robinson and J. B. Justice. Elsevier Science, Amsterdam.
229. Ursin R. Differential effect of para-chlorophenylalanine on the two slow wave sleep stages in the cat. Acta Physiol. Scand. 86:1972;278-285.
230. Ursin R. The effects of 5-hydroxytryptophan and L-tryptophan on wakefulness and sleep patterns in the cat. Brain Res. 106:1976;105-115.
231. Ursin R. Does para-chlorophenylalaninae produce disturbed waking, disturbed sleep or activation by ponto-geniculo-occipital waves in cats? Waking Sleeping. 4:1980;211-221.
232. Ursin R., Bjorvatn B. Sleep-wake and EEG effects following adenosine A1 agonism and antagonism: similarities and interactions with sleep-wake and EEG effects following a serotonin reuptake inhibitor in rats. Sleep Res. Online. 1:1998;119-127.
233. Ursin, R. and Sterman, M. B. (1981) A Manual for Standardized Scoring of Sleep and Waking States in the Adult Cat. Brain Information Service/Brain Research Institute, University of California, Los Angeles.
234. Ursin R., Bjorvatn B., Sommerfelt L., Underland G. Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to rats. Behav. Brain Res. 34:1989;117-130.
235. Van Bemmel A.L., Van den Hoofdakker R.H., Beersma D.G.M., Bouhuys A.L. Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram. Psychopharmacology. 113:1993;231-236.
236. 1B agonist CP-93,129 increases the secretion of ACTH, prolactin, and renin and increases blood pressure by nonserotonergic mechanisms. Pharmac. Biochem. Behav. 48:1994;429-436.
237. Vanderwolf, C. H., Baker, G. B. and Dickson, C. (1990) Serotonergic control of cerebral activity and behavior: models of dementia. In: The Neuropharmacology of Serotonin, pp. 366-382. Annals of the New York Academy of Sciences, Vol. 600. New York Academy of Sciences, New York.
238. Veasey S.C., Fornal C.A., Metzler C.W., Jacobs B.L. Single-unit responses of serotonergic dorsal raphe neurons to specific motor challenges in freely moving cats. Neuroscience. 79(1):1997;161.
239. Vertes R.P. Brainstem generation of the hippocampal EEG. Prog. Neurobiol. 19:1982;159.
240. Wang R.Y., Aghajanian G.K. Antidromically identified serotonergic neurons in the rat midbrain raphe: evidence for collateral inhibition. Brain Res. 132:1977;186.
241. Wang R.Y., Aghajanian G.K. Collateral inhibition of serotonergic neurons in the rat dorsal raphe nucleus: pharmacological evidence. Neuropharmacology. 17:1978;819.
242. Westerink, B. H. C. and Justice, J. B. (1991) Microdialysis compared with other in vivo release models. In: Microdialysis in the Neurosciences, pp. 23-46. Eds. T. E. Robinson and J. B. Justice. Elsevier Science, Amsterdam.
243. Wilkinson L.O., Auerbach S.B., Jacobs B.L. Extracellular serotonin levels change with behavioral state but not with pyrogen-induced hyperthermia. J. Neurosci. 11(9):1991;2732.
244. Williams J.H., Azmitia E.C. Hippocampal serotonin re-uptake and nocturnal locomotor activity after microinjections of 5,7-DHT in the fornix-fimbria. Brain Res. 207:1981;95.
245. Wilson J.R., Hendrickson A.E. Serotonergic axons in the monkey's lateral geniculate nucleus. Visual Neurosci. 6:1988;2779.
246. Wojcik W.J., Fornal C., Radulovacki M. Effect of tryptophan on sleep in the rat. Neuropharmacology. 19:1980;163.
247. 2 agonist, DOI, on 5-HT neuronal firing in the dorsal raphe nucleus and 5-HT release and metabolism in the frontal cortex. Br. J. Pharmac. 99(2):1990;221.
248. Yamamoto T., Watanabe S., Oishi R., Ueki S. Effects of midbrain raphe stimulation and lesion on EEG activity in rats. Brain Res. Bull. 4:1979;491.
249. Yoshimura M., Higashi H. 5-Hydroxytriptamine mediates inhibitory postsynaptic potentials in the rat dorsal raphe neurons. Neurosci. Lett. 53:1985;69.